HRMY - Latest News

Harmony Biosciences Holdings, Inc. (HRMY), operates in Healthcare / Biotechnology, trades on NASDAQ.

Market capitalization stands near $2.21B. Trailing twelve-month P/E ratio is 12.17. Beta to the broader market is 0.91.

The article list below shows the most recent HRMY headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent HRMY Headlines

Harmony Biosciences Highlights Record WAKIX Growth, Advances Orexin and Epilepsy Pipeline

marketbeat.com - Aug 14, 2026

Harmony Biosciences NASDAQ: HRMY highlighted record quarterly performance for its narcolepsy treatment WAKIX and outlined development plans across its

Harmony Biosciences Holdings, Inc. $HRMY Position Raised by California State Teachers Retirement System

defenseworld.net - Aug 13, 2026

California State Teachers Retirement System raised its position in shares of Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) by 40.

4 Healthcare Stocks to Watch as Defensive Demand Strengthens

zacks.com - Aug 7, 2026

Healthcare's defensive demand is strengthening in 2026. BTSG, HRMY, UNH and NVCR stand out on improving earnings outlooks and steady sector momentum.

4 Stocks Trading Near 52-Week High With More Upside Potential

zacks.com - Aug 6, 2026

Stocks like SNX, AMP, HRMY and NWL are seeing price strength and have a high chance of carrying the momentum forward.

Harmony Biosciences to Participate in Piper Sandler Virtual CNS Symposium

globenewswire.com - Aug 6, 2026

PLYMOUTH MEETING, Pa. , Aug.

How News Affects HRMY Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track HRMY's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked HRMY news questions

What is the latest HRMY news headline?
The most recent HRMY headline (Aug 14, 2026) is "Harmony Biosciences Highlights Record WAKIX Growth, Advances Orexin and Epilepsy Pipeline". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
How fresh is the HRMY news on this page?
News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
What HRMY news moves options pricing?
Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
How can I track unusual HRMY options activity related to news?
Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.